This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NextGen Healthcare Selected By Minnesota Eye Consultants To Aid In Enhancing Clinical Care Through Automation

NextGen Healthcare Information Systems,LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Minnesota Eye Consultants to deploy NextGen® Ambulatory EHR and NextGen® Practice Management across its enterprise. The renowned ophthalmology group joins a growing number of eye clinics currently served by NextGen Healthcare, including more than 500 ophthalmology practices nationwide, representing more than 52 percent of the market.

Minnesota Eye Consultants currently operates three ambulatory surgery centers, five laser and refractive surgery centers, with 10 clinic locations (five in the Twin Cities metro area and five in greater Minnesota). As one of the premier ophthalmology surgery centers in the nation, Minnesota Eye Consultants places a strong emphasis on education, research and training for ophthalmologists and surgeons from around the world. NextGen Ambulatory EHR will enable the group to enhance its extensive clinical research trials program with a goal to expand their comprehensive disease management capabilities. Additionally, NextGen Practice Management will aid in optimizing operational efficiencies by automating business processes that currently drain staff resources and capturing accurate measurement data.

“Based on NextGen’s strong presence and expertise in the ophthalmology arena, we believe that we can better automate our processes and enhance our clinical care by leveraging the industry’s leading software platform with our knowledge and experience,” said Dr. Richard L. Lindstrom, founder and attending surgeon of Minnesota Eye Consultants. “Our overall mission is to provide the highest quality surgical eye care to our patients, and, with NextGen, we found a partner with a proven track record that shares our vision for improving patient outcomes and achieving concrete results in the ophthalmology market.”

“Ophthalmology practices have always been at the forefront in terms of incorporating the latest technology in innovative ways,” said Scott Decker, president of NextGen Healthcare. “As one of the leading eye care groups in the nation, Minnesota Eye Consultants will strive to further elevate their leadership position by utilizing our technologies to strengthen their ability to optimize the patient experience and more effectively coordinate care.”

NextGen Healthcare will be showcasing its ophthalmology-related applications at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Symposium and Congress, April 20-24 in Chicago, booth #361.

For more information and case studies on NextGen® solutions for ophthalmology, please visit http://www.nextgen.com/Specialties/Ophthalmology/Ophthalmology.aspx.

About Minnesota Eye Consultants, P.A.

Minnesota Eye Consultants, P.A. is a nationally recognized ophthalmology practice with a reputation for handling the most difficult and complicated cases, specializing in refractive surgery subspecialists in cornea, glaucoma and oculoplastics. The practice is committed to education and research with a cornea fellowship training program, a residency training program for optometry and ongoing involvement in numerous teaching programs for new technologies. With a dedicated research department, Minnesota Eye regular participates in FDA investigational studies and studies for FDA approved devices. Call 1-800-Eye-to-Eye or visit www.mneye.com for more information.

About NextGen Healthcare

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright © 2012 NextGen Healthcare Information Systems, LLC. All rights reserved.

NextGen is either a registered trademark or trademark of NextGen Healthcare Information Systems, LLC., in the United States and/or other countries. All other names and marks are property of their respective owners.

Patent pending.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,372.93 +21.55 0.13%
S&P 500 1,960.64 +11.78 0.60%
NASDAQ 4,763.1680 +13.1890 0.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs